The COVID-19 relief package—American Rescue Plan Act of 2021—which was signed into law in March of this year, provided the United States Health Resources and Services Administration with $900 million to retain the current medical and dental…

The United States Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have paused the federal use of the Johnson and Johnson (J&J) COVID-19 vaccine due to the rare but serious risk of blood clots…

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, noted that shortages of personal protective equipment (PPE) contributed to the loss of more than 3,600 healthcare professionals’ lives during the…

On April 8, more 70,000 appointments were available for Mississippians to receive a COVID-19 vaccination; however, many in the state are declining to be inoculated. With large populations of Republican voters and Black residents—two groups…

While many Americans are getting vaccinated against SARS-CoV-2, a significant percentage (about 30%) state they will decline it for a variety of reasons. Whether private employers, travel operators, and other entities can mandate…

Scientists at the National Institutes of Health (NIH) are hard at work trying to create a pill that would effectively treat COVID-19 illness, just as Tamiflu does for influenza. The goal is an oral medication that would neutralize…

A study recently published in the Journal of the American Academy of Dermatology found that the skin reactions commonly seen post-COVID-19 vaccination resolve quickly and are not indicative of any serious medical condition. The study…

New research out of England’s Oxford University found that one in three survivors of COVID-19 illness experienced a neurological or psychiatric disorder within 6 months of recovery. Including more than 230,000 subjects—mostly from the…

Although more than 3 million COVID-19 shots are delivered daily across the United States, only about 18.5% of Americans are fully vaccinated against SARS-CoV-2. This leaves the door open for a dreaded fourth surge of COVID-19 illness.…

Currently in clinical trials in Brazil, Thailand, and Vietnam, a new COVID-19 immunization called NVD-HXP-S may help low- and middle-income countries ensure their residents can get vaccinated against the novel coronavirus. NVD-HXP-S is a…